We also detected Nucleoside diphosphate kinase 3(NDKA) in stage 3 breast cancer sample, aligning with the finding of Otero-Estévez and collaborators that a decrease in NDKA protein and mRNA has been associated with an increase in metastatic potential and poor prognosis in breast cancer. The gene discussed is NME3; the disease is breast carcinoma.